D. E. Shaw & Co., Inc. Uni Qure N.V. Put Options Transaction History

D. E. Shaw & Co., Inc.

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2020 Nov 16, 2020	SELL	$35.98 - $47.66 $1.08 Million - $1.43 Million	-30,000 Reduced 75.0%	10,000 $368,000
Q2 2020 Aug 14, 2020	SELL	$45.06 - $67.74 $4,506 - $6,773	-100 Reduced 0.25%	40,000 $1.8 Million
Q1 2020 May 15, 2020	BUY	$40.01 - $73.97 $1.2 Million - $2.23 Million	30,100 Added 301.0%	40,100 $1.9 Million
Q2 2019 Aug 14, 2019	BUY	$52.76 - $82.19 $527,600 - $821,900	10,000 New	10,000 $782,000

140

33.7M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $264M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.